Shanghai Junshi Biosciences Expects 2025 Revenue to Rise 28% to RMB2.5 Billion
I'm PortAI, I can summarize articles.
Shanghai Junshi Biosciences Co. Ltd. forecasts a 28% increase in revenue for 2025, estimating approximately RMB2.5 billion, up from RMB1.94 billion in 2024. This projection indicates a significant improvement in the company's business performance. The information was published via the Issuer Information Service of the Hong Kong Stock Exchange.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments